Variant report

Variant	nsv556388
Chromosome Location	chr11:107655949-107673300
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:0)
CpG islands
(count:0)
Chromatin interactive
region (count:5)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:1)

No data

(count:5 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr11:107663159..107665072-chr11:107667163..107669875,2	MCF-7	breast:
2	chr11:107663159..107665072-chr11:107667163..107669875,2	MCF-7	breast:
3	chr11:107670081..107670628-chr11:107695151..107695710,2	K562	blood:
4	chr11:107670116..107670647-chr11:107768751..107769447,2	MCF-7	breast:
5	chr11:107646046..107648383-chr11:107654593..107656210,2	MCF-7	breast:

No data

(count:1 , 50 per page) page: 1

No.	miRNA target gene	miRNA name	Chromosome Location	mirBase accession
1	SLC35F2	hsa-miR-155-5p	chr11:107662756-107662777

Extended variants
information (count: 812 )
Associated
traits (count: 102 )

Variant overlapped rSNPs/rCNVs (count:812 , 50 per page) page: 1 2 3 4 5 6 7 ... 17

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs607506	chr11:107655949-107655950	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
2	rs374690163	chr11:107655969-107655970	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
3	rs549635745	chr11:107655973-107655974	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
4	rs7129372	chr11:107655990-107655991	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
5	rs142395316	chr11:107655991-107655992	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
6	rs368419732	chr11:107655992-107655993	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
7	rs184230335	chr11:107656014-107656015	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
8	rs549838472	chr11:107656026-107656027	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
9	rs189595787	chr11:107656034-107656035	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
10	rs113899418	chr11:107656075-107656076	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
11	rs553370567	chr11:107656100-107656101	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
12	rs572367559	chr11:107656108-107656109	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
13	rs55635753	chr11:107656172-107656173	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
14	rs114853696	chr11:107656222-107656223	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
15	rs576577264	chr11:107656226-107656227	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
16	rs562524085	chr11:107656234-107656235	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
17	rs543701032	chr11:107656242-107656243	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
18	rs116992148	chr11:107656254-107656255	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
19	rs185083709	chr11:107656269-107656270	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
20	rs188893388	chr11:107656289-107656290	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
21	rs552043132	chr11:107656312-107656313	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
22	rs372827478	chr11:107656342-107656343	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
23	rs559801613	chr11:107656349-107656350	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
24	rs568095346	chr11:107656351-107656352	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
25	rs527544757	chr11:107656364-107656365	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
26	rs115540840	chr11:107656372-107656373	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
27	rs377384289	chr11:107656424-107656425	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
28	rs561068685	chr11:107656463-107656464	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
29	rs535509564	chr11:107656472-107656473	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
30	rs181634650	chr11:107656584-107656585	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
31	rs55890119	chr11:107656591-107656592	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
32	rs549735737	chr11:107656618-107656619	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
33	rs547341134	chr11:107656652-107656653	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
34	rs114371044	chr11:107656657-107656658	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
35	rs538361216	chr11:107656705-107656706	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
36	rs546945830	chr11:107656712-107656713	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
37	rs146081811	chr11:107656726-107656727	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
38	rs186338222	chr11:107656742-107656743	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
39	rs555238028	chr11:107656778-107656779	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
40	rs116897062	chr11:107656920-107656921	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
41	rs375724560	chr11:107656926-107656927	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
42	rs537630697	chr11:107656930-107656931	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
43	rs567336434	chr11:107656931-107656932	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
44	rs377005857	chr11:107657029-107657030	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
45	rs536337772	chr11:107657085-107657086	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
46	rs541548841	chr11:107657115-107657116	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
47	rs190942532	chr11:107657118-107657119	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
48	rs574765618	chr11:107657129-107657130	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
49	rs541893253	chr11:107657156-107657157	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
50	rs533135931	chr11:107657169-107657170	Weak transcription	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:102)

Disease	PMID	Source
Medulloblastoma	21979893	CNVD
Gastric cancer	17908304	CNVD
Multiple myeloma	20724749	CNVD
Wilms tumour	21544195	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Intellectual disability	22102821	CNVD
Autism	22495311	CNVD
Acute myeloid leukemia	20729466	CNVD
Cancer	21637783	CNVD
Acute myeloid leukemia	16864856	CNVD
Chronic lymphocytic leukemia	21795749	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Neuroblastoma	21484798	CNVD
Ewing''s sarcoma	21437220	CNVD
Oral cancer	21386901	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	20837533	CNVD
Breast cancer	21264507	CNVD
Cervical cancer	21063398	CNVD
Glioblastoma multiforme	19960244	CNVD
Liposarcoma	21253554	CNVD
Neuroblastoma	18923524	CNVD
Neuroblastoma	18664255	CNVD
Monoclonal gammopathy of undetermined significance	17077331	CNVD
Multiple myeloma	17077331	CNVD
Neuroblastoma	17533364	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Glioblastoma multiforme	21080181	CNVD
Cancer	16751803	CNVD
Seminomas	18059402	CNVD
Cervical cancer	21062161	CNVD
Esophageal squamous carcinoma	18350619	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
lymphocytic leukemia	21291569	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Neuroblastoma	18923191	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Cancer	22429812	CNVD
Breast cancer	16608533	CNVD
T-cell lymphomas	19863542	CNVD
Melanoma	18172304	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Basal cell lymphoma	17053054	CNVD
Hepatocellular carcinoma	16785998	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Acute myeloid leukemia	21251322	CNVD
Breast cancer	21858162	CNVD
Breast cancer	21785460	CNVD
Breast cancer	21958427	CNVD
Lung cancer	18438408	CNVD
Ewing''s sarcoma	17952124	CNVD
Breast cancer	17133270	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Acute lymphoblastic leukemia	21098271	CNVD
small cell lung cancer	20016488	CNVD
Breast cancer	17603634	CNVD
T-cell acute lymphoblastic leukemia	18185524	CNVD
Basal cell lymphoma	16790693	CNVD
Chronic lymphocytic leukemia	21670202	CNVD
Breast cancer	21364760	CNVD
Ovarian clear cell carcinoma	19293255	CNVD
Mental retardation	19966786	CNVD
Non-small cell lung cancer	21829676	CNVD
Invasive pancreatic ductal carcinoma	16982739	CNVD
Intracranial aneurysm	16715129	CNVD
Ovine squamous-cell carcinoma	17599052	CNVD
Basal cell lymphoma	17170743	CNVD
Follicular lymphoma	17170743	CNVD
Urothelial carcinoma	21177765	CNVD
Myelofibrosis	22110671	CNVD
Ovarian cancer	21720365	CNVD
Chronic lymphocytic leukemia	17805327	CNVD
Glioblastoma multiforme	22286061	CNVD
Breast cancer	16397240	CNVD
Chronic lymphocytic leukemia	18922857	CNVD
Neuroblastoma	17327916	CNVD
Esophageal adenocarcinoma	18519675	CNVD
Esophageal squamous carcinoma	17470683	CNVD
Mantle cell lymphoma	19029149	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Malignant melanoma	17260012	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Prostate cancer	16573809	CNVD
Prostate cancer	18632612	CNVD
Obesity	19966786	CNVD
Renal cell carcinoma	21668985	CNVD
Cancer	20164920	CNVD
Acute lymphoblastic leukemia	18458336	CNVD
Attention deficit hyperactivity disorder	19546859	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Cancer	20164919	CNVD
Breast cancer	22522925	CNVD
Pancreatic cancer	17952125	CNVD
Cancer	17440070	CNVD

Chromatin state (count:252 , 50 per page) page: 1 2 3 4 5 6

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr11:107648400-107656000	Weak transcription	GM12878-XiMat	blood
2	chr11:107652000-107665000	Weak transcription	A549	lung
3	chr11:107654000-107676800	Weak transcription	NH-A	brain
4	chr11:107655400-107657000	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
5	chr11:107655400-107662800	Weak transcription	Rectal Mucosa Donor 31	rectum
6	chr11:107655800-107656600	Enhancers	Osteobl	bone
7	chr11:107655800-107657000	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
8	chr11:107656000-107656200	Enhancers	GM12878-XiMat	blood
9	chr11:107656200-107656400	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
10	chr11:107656200-107656600	Enhancers	iPS-15b Cell Line	embryonic stem cell
11	chr11:107656200-107656800	Enhancers	K562	blood
12	chr11:107656200-107662200	Weak transcription	GM12878-XiMat	blood
13	chr11:107656400-107656600	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
14	chr11:107656400-107656600	Enhancers	Muscle Satellite Cultured Cells	--
15	chr11:107656400-107657800	Weak transcription	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
16	chr11:107656600-107658000	Weak transcription	iPS-15b Cell Line	embryonic stem cell
17	chr11:107656600-107663000	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
18	chr11:107656600-107673400	Weak transcription	Muscle Satellite Cultured Cells	--
19	chr11:107656600-107679800	Weak transcription	Osteobl	bone
20	chr11:107656800-107657000	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
21	chr11:107656800-107673800	Weak transcription	K562	blood
22	chr11:107657000-107662200	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
23	chr11:107657000-107662200	Weak transcription	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
24	chr11:107657000-107662600	Weak transcription	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
25	chr11:107657800-107658000	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
26	chr11:107658000-107658800	Weak transcription	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
27	chr11:107658000-107659000	Enhancers	iPS-15b Cell Line	embryonic stem cell
28	chr11:107658200-107658600	Enhancers	Placenta Amnion	Placenta Amnion
29	chr11:107658200-107658800	Enhancers	HUES48 Cell Line	embryonic stem cell
30	chr11:107658200-107658800	Enhancers	NHEK	skin
31	chr11:107658200-107659200	Enhancers	HUES6 Cell Line	embryonic stem cell
32	chr11:107658200-107659200	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
33	chr11:107658200-107659400	Enhancers	ES-I3 Cell Line	embryonic stem cell
34	chr11:107658400-107658600	Enhancers	ES-WA7 Cell Line	embryonic stem cell
35	chr11:107658400-107658600	Enhancers	HUES64 Cell Line	embryonic stem cell
36	chr11:107658400-107659200	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
37	chr11:107658600-107658800	Enhancers	H1 Cell Line	embryonic stem cell
38	chr11:107658600-107658800	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
39	chr11:107658600-107662600	Weak transcription	Placenta Amnion	Placenta Amnion
40	chr11:107658600-107665600	Weak transcription	HUES64 Cell Line	embryonic stem cell
41	chr11:107658800-107660600	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
42	chr11:107658800-107660800	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
43	chr11:107658800-107662200	Weak transcription	NHEK	skin
44	chr11:107658800-107663200	Weak transcription	HUES48 Cell Line	embryonic stem cell
45	chr11:107658800-107679000	Weak transcription	H1 Cell Line	embryonic stem cell
46	chr11:107658800-107680600	Weak transcription	Small Intestine	intestine
47	chr11:107659000-107662400	Weak transcription	Duodenum Mucosa	Duodenum
48	chr11:107659000-107662800	Weak transcription	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
49	chr11:107659000-107679200	Weak transcription	iPS-15b Cell Line	embryonic stem cell
50	chr11:107659200-107660400	Weak transcription	Foreskin Keratinocyte Primary Cells skin02	Skin

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links